Amantadine Therapy for Chronic Hepatitis C: A Randomized Double-blind Placebo-controlled Trial

OBJECTIVE: Although treatment of hepatitis C has improved, up to 50% do not respond to standard therapy with interferon regimes or cannot tolerate the treatment due to side effects. The purpose of the present investigation was to evaluate the safety and effectiveness of the antiviral drug amantadine...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Smith, Jill P, Riley, Thomas R, Devenyi, Attila, Bingaman, Sandra I, Kunselman, Allen
Format: Artigo
Sprache:Inglês
Veröffentlicht: Blackwell Science Inc 2004
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1492374/
https://ncbi.nlm.nih.gov/pubmed/15209605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1525-1497.2004.30057.x
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge